Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii  M. Bernabeu-Wittel, A. García-Curiel,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis  E.V. Lemos, F.P. de la Hoz,
Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina  S.
Gut bacterial microbiota and obesity
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
Approach to diagnosis of infective endocarditis
In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin- resistant Acinetobacter baumannii  X. Vila-Farres, C. Garcia.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit  A. Tsakris, A. Ikonomidis,
Management of post-neurosurgical meningitis: narrative review
Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain  J. Ruiz, M.M. Navia, C. Casals, J.M. Sierra, M.T.
Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.
R. Cantón  Clinical Microbiology and Infection 
A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU  P.G. Higgins, H. Wisplinghoff, O. Krut, H.
The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents  S. Brown, S.G.B. Amyes  Clinical.
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi 
PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and.
Vector control: a cornerstone in the malaria elimination campaign
OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii  B.A. Evans, A. Hamouda, K.J. Towner, S.G.B.
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
E.C. Böttger  Clinical Microbiology and Infection 
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health  R.M. Davies  Clinical Microbiology and Infection 
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W
B. Sádaba, J.R. Azanza, M.A. Campanero, E. García-Quetglas 
Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia  E.V. Lemos, F.P.
The practice of travel medicine in Europe
M. -J. Rodríguez-Hernández, M. E. Jiménez-Mejias, C. Pichardo, L
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
P.M. Hawkey  Clinical Microbiology and Infection 
Activity of cefepime and carbapenems in experimental pneumonia caused by porin- deficient Klebsiella pneumoniae producing FOX-5 β-lactamase  C. Pichardo,
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?  G.L. Daikos, A. Markogiannakis  Clinical Microbiology.
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
F.J. Pastor, J. Guarro  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals  R.A. Bonnin, L. Poirel, M. Licker, P. Nordmann 
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii  M. Bernabeu-Wittel, A. García-Curiel, C. Pichardo, M.E. Pachón-Ibáñez, M.E. Jiménez-Mejías, J. Pachón  Clinical Microbiology and Infection  Volume 10, Issue 10, Pages 931-934 (October 2004) DOI: 10.1111/j.1469-0691.2004.00944.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Photomicrograph (×100) of a Gram's stain of a carbapenem-susceptible strain of A. baumannii exposed to imipenem at concentrations 0.25 × MIC for 4 h. A significant number of spheroplasts ≥ 3 µm in size can be seen. Clinical Microbiology and Infection 2004 10, 931-934DOI: (10.1111/j.1469-0691.2004.00944.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.